Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Medical Genetics|February 1, 2021
Genetic counseling for women with 45,X/46,XX mosaicism: Towards more personalized managementEmma A Snyder, Adrianna K San Roman, Raul E Piña-Aguilar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 22, 2018
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice GuidelineShalender Bhasin, Juan P Brito, Glenn R Cunningham, et al.
The New England Journal of Medicine|September 1, 2007
Reversal of idiopathic hypogonadotropic hypogonadismTaneli Raivio, John Falardeau, Andrew Dwyer, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 21, 2007
Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the ArchitectPatrick M Sluss, Frances J Hayes, Judith M Adams, et al.
European Journal of Endocrinology|November 1, 2006
Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadismFelecia Cerrato, Jenna Shagoury, Milena Kralickova, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2014
Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine systemValerie F Sidhoum, Yee-Ming Chan, Margaret F Lippincott, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2006
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismNelly Pitteloud, James S Acierno, Astrid Meysing, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2009
Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadismTaneli Raivio, Yisrael Sidis, Lacey Plummer, et al.
The Journal of Clinical Endocrinology and Metabolism|June 19, 2008
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrumLindsay W Cole, Yisrael Sidis, ChengKang Zhang, et al.
The Journal of Clinical Investigation|January 20, 2007
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadismNelly Pitteloud, Richard Quinton, Simon Pearce, et al.
Pageof 5